Diagnostic Testing of STDs are used for identification and diagnosis of sexually transmitted diseases. These diseases are transmitted through person-to-person sexual contact. Approval and launch of new diagnostic tests is expected to propel growth of the global diagnostic testing of STDs market over the forecast period. Moreover, increasing incidence of STDs in developing and developed economies along with increasing awareness is also expected to drive the market growth during the forecast period.
Key features of the study:
- This report provides in-depth analysis of the Global Diagnostic Testing of STDs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the Global Diagnostic Testing of STDs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The Global Diagnostic Testing of STDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Diagnostic Testing of STDs market
Detailed Segmentation:
- Global Diagnostic Testing of STDs Market, By Test Type:
- Chlamydia
- Gonorrhea
- Syphilis
- HIV
- HPV+pap smear
- HSV
- Chancroid
- Global Diagnostic Testing of STDs Market, By Region:
- North America
- By Test Type:
- Chlamydia
- Gonorrhea
- Syphilis
- HIV
- HPV+pap smear
- HSV
- Chancroid
- By Country
- U.S.
- Canada
- Latin America
- By Test Type:
- Chlamydia
- Gonorrhea
- Syphilis
- HIV
- HPV+pap smear
- HSV
- Chancroid
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Test Type:
- Chlamydia
- Gonorrhea
- Syphilis
- HIV
- HPV+pap smear
- HSV
- Chancroid
- By Country
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- By Test Type:
- Chlamydia
- Gonorrhea
- Syphilis
- HIV
- HPV+pap smear
- HSV
- Chancroid
- By Country
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Test Type:
- Chlamydia
- Gonorrhea
- Syphilis
- HIV
- HPV+pap smear
- HSV
- Chancroid
- By Country
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- By Test Type:
- Chlamydia
- Gonorrhea
- Syphilis
- HIV
- HPV+pap smear
- HSV
- Chancroid
- By Country
- North Africa
- Central Africa
- South Africa
- Company Profiles
- Vela Diagnostics USA Inc. *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Roche Holdings AG
- Alere, Inc.
- Becton Dickinson & Company
- bioMerieux
- Danaher Corporation (Beckman Coulter)
- Hologic, Inc.
- binx health
- Chembio Diagnostics
- Pinpoint Science Inc.
- bioLytical Laboratories
- "*" marked represents similar segmentation in other categories in the respective section.